Documentos de Ordaz-Rosado D. | REDI

Regresar

Mostrando 4 resultados de: 4

Filtros aplicados

Palabras Claves: "Breast Cancer"

Subtipo de publicación

Publisher

Bioorganic and Medicinal Chemistry(1)

Experimental Cell Research(1)

Área temáticas

Enfermedades(4)

Farmacología y terapéutica(3)

Ginecología, obstetricia, pediatría, geriatría(1)

Salud y seguridad personal(1)

Área de conocimiento

Farmacología(2)

Biología molecular(1)

Año de Publicación

Origen

Palabras Claves

Estrogen receptor(2)

Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells

Abstract: Antiproliferative actions of calcitriol have been shown to occur in many cell types; however, little

Palabras claves:

Astemizole, Breast Cancer, K channels +, TEI-9647, VDR, vitamin D

Arrecillas M., Avila-Chávez E., Bargallo E., David B., Díaz L., García-Becerra R., Halhali A., Javier Camacho, Larrea F., Morales A., Ordaz-Rosado D., Ortiz C.S.

Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach

Abstract: Background: Approximately 30% of breast tumors do not express the estrogen receptor (ER) α, which is

Palabras claves:

Breast Cancer, Calcitriol, Estrogen receptor, Hormonal therapy, VDR

Avila-Chávez E., David B., Díaz L., Esparza-López J., García-Becerra R., García-Quiroz J., Halhali A., Ibarra-Sánchez M., Javier Camacho, Larrea F., Medina-Franco H., Ordaz-Rosado D., Santos-Martínez N.

Genomic action of permanently charged tamoxifen derivatives via estrogen receptor-α

Abstract: Tamoxifen is a selective estrogen receptor modulator widely used in oncology and reproductive endocr

Palabras claves:

Breast Cancer, Estrogen receptor, Genomic action, Tamoxifen, Tamoxifen derivatives

Bravo-Gómez M.E., Cooney A.J., García-Becerra R., Hernández-gallegos E., Javier Camacho, Larrea F., Morales-Ríos M.S., Ordaz-Rosado D., Pérez-Alvarez V., Rivera-Guevara C.

In vivo dual targeting of the oncogenic ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors

Abstract: Background: The oncogenic ether-à-go-go-1 potassium channel (EAG1) activity and expression are neces

Palabras claves:

Breast Cancer, Eag1, Ki-67, Targeted therapy, vitamin D, Vitamin D receptor

Avila-Chávez E., David B., Díaz L., Esparza-López J., Gamboa-Dominguez A., García-Becerra R., García-Quiroz J., Halhali A., Ibarra-Sánchez M., Javier Camacho, Larrea F., Ordaz-Rosado D., Santos-Martínez N., Villanueva O.